Eli Lilly and Company - Deferred Long Term Liabilities

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The indicator "Deferred-Long-Term-Liabilities" stands at 0.0873 Billion United States Dollars as of 12/31/2022, the lowest value at least since 06/30/2019, the period currently displayed. Regarding the Three-Year-Change of the series, the current value constitutes a decrease of -96.01 percent compared to the value three years prior.
The 3 year change in percent is -96.01.

The Serie's long term average value is 1.70 Billion United States Dollars. It's latest available value, on 12/31/2022, is 94.87 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2022, to it's latest available value, on 12/31/2022, is +0.0%.
The Serie's change in percent from it's maximum value, on 09/30/2019, to it's latest available value, on 12/31/2022, is -96.38%.